Fierce Pharma

MARCH 20, 2023

in 2022 pay as stock price hit all-time high aliu Mon, 03/20/2023 - 10:51 Eli Lilly CEO racked up $21.4M

235

235

European Pharmaceutical Review

JANUARY 17, 2023

The Cell and Gene Therapy (CGT) Catapult has published its ‘ UK Advanced Therapy Medicinal Products (ATMP) Clinical Trials Report 2022 ’. The research observed this cell type took up 58 percent of UK ATMP clinical trials in 2022. . The number of Phase II/III trials increased from three trials in 2021 to seven trials in 2022.

Medicine 119

Medicine Pharmaceutical 119

pharmaphorum

OCTOBER 13, 2022

Day 2 coverage: Click here to read Reuters: Pharma 2022 Day 1 overview. Click here or the image below to read Reuters: Pharma 2022 Live coverage. The post Reuters Pharma 2022 – Day 2 coverage appeared first on.

Pharma 95

Pharma 95

pharmaphorum

OCTOBER 14, 2022

Day 3 coverage: Click here to read Reuters: Pharma 2022 Day 1 overview. Click here or the image below to read Reuters: Pharma 2022 Day 2 coverage. The post Reuters Pharma 2022 – Day 3 coverage appeared first on.

Pharma 95

Pharma 95

pharmaphorum

NOVEMBER 15, 2022

The post HLTH 2022 – Day 2 appeared first on. A highlight of the afternoon should be hearing from two major healthcare leaders at Amazon: VP of Health Aaron Martin and Chief Medical Officer Nworah Ayogu. Then more pharma voices with panels featuring speakers from Bristol Myers Squibb and AstraZeneca.

Pharma 116

Pharma Healthcare Healthcare Medical 116

pharmaphorum

OCTOBER 20, 2022

When it comes to knowing what’s currently what in digital transformation, be sure to stay tuned and not miss out on coverage of Day Two of Frontiers Health 2022, brought to you LIVE from Milan! The post Frontiers Health 2022 – day 2 appeared first on. Click here or the image below to read Frontiers Health Day 1 coverage.

Healthcare 113

Healthcare Healthcare Sales Marketing 113

European Pharmaceutical Review

AUGUST 10, 2022

On 23 July 2022, the World Health Organization (WHO) Director-General, Dr Tedros Adhanom Ghebreyesus, declared the multi-country outbreak of monkeypox a public health emergency of international concern. As of 2 August 2022, the UK had 2,739 confirmed cases, 4 the majority occurring within London, England. Current case rates.

Food and Drug Administration 96

Food and Drug Administration Medicine Government FDA 96

European Pharmaceutical Review

JANUARY 16, 2023

This Q&A covers the key developments in pharmaceutical microbiology in 2022, featuring insight from pharmaceutical microbiology experts: Dr Tim Sandle, Head of Microbiology, Bio Products Laboratory Limited. Regulation, particularly Annex 1, was identified as a key focus for 2022.

Pharmaceutical 128

Pharmaceutical Food and Drug Administration Manufacturing Medicine 128

pharmaphorum

OCTOBER 19, 2022

Frontiers Health 2022 in Milan is LIVE! The post Frontiers Health 2022 – day 1 appeared first on. Opening Day One will be Healthware Group’s CEO and founder Roberto Ascione and WTF Health’s founder and host Jessica DaMassa. As the day begins with an energising networking espresso, so shall it close with a ruminating aperitivo.

Networking 103

Networking Management Medical 103

pharmaphorum

OCTOBER 31, 2022

Between the 2nd and 4th November, a veritable who’s who of British industry will gather at the Eden Project in Boldeva, Cornwall for Anthropy 2022, the event’s second year. The post Anthropy 2022 appeared first on. Over three days and across 12 stages within multiple biomes, over 130 sessions will take place, including 300 speakers.

Pharma 87

Pharma Pharmaceutical Patients 87

European Pharmaceutical Review

FEBRUARY 20, 2023

According to a new report on UK life sciences recruitment, there were 11,200 new professional scientific vacancies in the industry across England and Wales in 2022. percent March 2022 was identified as the peak month for scientific jobs in the Pharmaceutical sector (586 vacancies, up 6.2 This represented a year-on-year decrease of -7.4

Recruitment 96

Recruitment Pharmaceutical Marketing Manufacturing 96

MedCity News

NOVEMBER 23, 2022

Among the takeaways from HLTH 2022 were the impact of consolidation on clinicians, behavioral health tools to help consumers manage stress and anxiety more productively, and how health tech and medtech companies are supporting remote patient monitoring and testing.

Management 93

Management Patients Physicians 93

European Pharmaceutical Review

MARCH 27, 2023

percent between 2022 and 2027. The research includes historic market data from 2017 to 2021, using 2022 as the base year. In the report, analysts showed North America was the largest revenue contributor to the global rapid microbiology testing market in 2022, with the US being the leading country. Don Whitley Scientific Ltd.,

Marketing 115

Marketing Pharmaceutical research Pharmaceutical Leads 115

Pharmaceutical Technology

NOVEMBER 2, 2022

Pfizer has reported a 6% decline in revenue to $22.6bn in the third quarter (Q3) of 2022 as against $24bn in the same quarter last year. The reported diluted earnings per share (EPS) for Q3 2022 stood at $1.51, compared to $1.42 The reported diluted earnings per share (EPS) for Q3 2022 stood at $1.51, compared to $1.42

Manufacturing 116

Manufacturing Pharmaceutical 116

MedCity News

JUNE 8, 2023

A new KFF analysis showed that Medicare spending per person increased to $15,700 in 2022 from $5,800 in 2000, representing a 4.6% average annual growth.

Healthcare 102

Healthcare Healthcare 102

Pharmaceutical Technology

FEBRUARY 1, 2023

Pfizer has reported a 30% operational growth in revenues to $100.3bn in full-year 2022 compared with $81.2bn reported last year. In the fourth quarter (Q4) of 2022, they increased 13% operationally to $24.3bn compared to $23.8bn in the same quarter last year. For Q4 2022, the reported diluted EPS stood at $0.87 as against $0.59

Pharmaceutical 104

Pharmaceutical Marketing Patients 104

European Pharmaceutical Review

JANUARY 12, 2023

The Sustainable Market Initiative’s (SMI) 2022 Terra Carta Seal , which recognises global companies who are driving innovation and leadership within their industry, has been awarded to pharmaceutical companies GlaxoSmithKline PLC, Sanofi, and Samsung Biologics. ” Biopharma successful in achieving climate-related goals, report finds.

Pharma 105

Pharma Biopharma Manufacturing Government 105

European Pharmaceutical Review

DECEMBER 19, 2022

EMA human medicines committee (CHMP) highlights, November 2022. The post CHMP meeting highlights – December 2022 appeared first on European Pharmaceutical Review.

Medicine 104

Medicine Marketing Patients Medical 104

Pharmaceutical Technology

NOVEMBER 11, 2022

AstraZeneca has reported an 11% rise in total revenue to $10.98bn in the third quarter (Q3) 2022 as against $9.87bn in the year-ago quarter. For the quarter ending on 30 September 2022, product sales were reported at $10.59bn from $9.7bn in Q3 last year, indicating a growth of 9%.

Food and Drug Administration 96

Food and Drug Administration Food FDA Sales 96

Copyright Clearance Center

JUNE 2, 2023

Across all sectors, US publishing sales in 2022 totaled $28.1 billion, according to the Association of American Publishers.

Sales 98

Sales 98

Clarivate

FEBRUARY 27, 2024

When global trademark filing activity fell in 2022 , questions rose around what this signified. Applications from Mainland China were up by 9% compared with 2022, while Polish applicants filed 19% more EUTM applications than in 2022. Mainland China – 21,701 (up by 9% compared to 2022) 2.

Marketing 98

Marketing Leads Management 98

Tribeca Knowledge

NOVEMBER 24, 2022

W ith only weeks left to run in 2022, new drug approvals across the two most important markets for the pharmaceutical industry were in only middling shape. In the US, however, 2022 new drug approvals seemed to be heading for a distinct slump.

Marketing 98

Marketing Medicine FDA Pharmaceutical 98

Pharmaceutical Technology

MARCH 2, 2023

to €22.23bn in fiscal 2022 against €19.68bn in 2021. in group sales in fiscal 2022. For fiscal 2022, Merck’s EBITDA increased by 9.4% Merck presented strong data in Healthcare from its 2022 pipeline about Phase II trials for xevinapant (head and neck cancer) and evobrutinib (multiple sclerosis). organic rise.

Sales 98

Sales Healthcare Healthcare Manufacturing 98

Pharmaceutical Technology

FEBRUARY 10, 2023

AbbVie has reported full-year 2022 net revenues of $58.054bn, representing a 3.3% on a reported basis in global net revenues to $15.121bn for the fourth quarter (Q4) of 2022. AbbVie chairman and CEO Richard Gonzalez said: “2022 was another highly productive year capping a decade of outstanding performance. on a reported basis.

Pharmaceutical 98

Pharmaceutical 98

Clarivate

JUNE 29, 2022

New brands in 2022 have been created during a time of unprecedented complexity and change and our latest report, Top 100 New Brands 2022 , tells their story. The Top 100 New Brands 2022 features 23 new brands from Mainland China, created and launched faster than ever before. Read Top 100 New Brands 2022 today.

Electronics 98

Electronics Retail Specialization Marketing 98

Pharmaceutical Technology

FEBRUARY 3, 2023

Merck (MSD outside North America) has reported a 2% increase in worldwide sales to $13.83bn in the fourth quarter (Q4) of 2022 from $13.52bn in the previous year’s quarter. Merck has reported a 22% increase in worldwide sales for the full-year 2022, to $59.28bn from $48.7bn in the prior-year quarter.

Sales 98

Sales Pharmaceutical Sales Engineering Pharmaceutical 98

pharmaphorum

NOVEMBER 2, 2022

Wednesday 2 nd November heralds the start of Anthropy 2022 at The Eden Project. The post Anthropy 2022 – Day One appeared first on.

Pharma 85

Pharma Healthcare Healthcare Leads 85

Pharmaceutical Technology

JULY 29, 2022

Pfizer has reported a 53% operational growth in revenues to $27.7bn in the second quarter (Q2) of 2022 compared to $18.9bn in the same quarter last year. In Q2 2022, Paxlovid, Comirnaty, Eliquis, Prevnar family (Prevnar 13 & 20) in the US and Vyndaqel/Vyndamax were the key drivers in operational growth. as against $0.98

Sales 105

Sales Pharmaceutical Patients 105

European Pharmaceutical Review

JULY 3, 2023

The Office of Pharmaceutical Quality (OPQ) in the US Food and Drug Administration (FDA)’s Center Pharmaceutical Quality for Drug Evaluation and Research (CDER) has released its 2022 annual report analysing drug manufacturers and their products.

Food and Drug Administration 105

Food and Drug Administration FDA Manufacturing Product sample 105

MedCity News

JANUARY 5, 2023

Fewer new drugs won FDA approvals in 2022 compared to previous years, but some of the products that passed regulatory muster are indicative of trends expected to continue into 2023. For example, more gene and cell therapies are on track to face regulatory decisions in the coming year.

FDA 120

FDA Biopharma Pharma 120

Pharmaceutical Technology

JUNE 29, 2022

The proportion of pharmaceutical companies hiring for AI related positions kept relatively steady in May 2022 compared with the equivalent month last year, with 39.3% in April 2022. When it came to the rate of all job openings that were linked to AI, related job postings dropped in May 2022 from April 2022, with 7.4%

Pharmaceutical 110

Pharmaceutical Recruitment 110

European Pharmaceutical Review

AUGUST 24, 2022

The post European Pharmaceutical Review Issue 4 2022 appeared first on European Pharmaceutical Review. Dominik Schumacher and Jonas Helma-Smets, Tubulis. BIOPROCESSING/BIOPRODUCTION. A collaborative approach to customising cell culture media. FUJIFILM Irvine Scientific.

Pharmaceutical 105

Pharmaceutical Consulting Media 105

European Pharmaceutical Review

NOVEMBER 15, 2022

The International Generic and Biosimilar Medicines Association (IGBA)’s new whitepaper Embracing Science with Confidence: Adopting the Revised 2022 WHO Biosimilars Guideline suggests how the guideline provides great opportunity to revaluate how regulatory requirements can better advance biosimilar access. WHO Biosimilar Guideline updates.

Medicine 98

Medicine Safety Healthcare Healthcare 98

PharmaVoice

NOVEMBER 21, 2022

Biopharma IPOs have puttered in 2022, particularly compared to the record-breaking previous year, but they might be set to rebound.

Biopharma 105

Biopharma 105